MktsMarkets

Structure Therapeutics Inc.
NASDAQ: GPCRKey statistics
GPCR News
Stories mentioning GPCR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 66,507 | 68,689 | 58,989 | 54,710 | 42,867 | 33,487 | 32,598 | 22,050 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 89,379 | (23,989) | 73,787 | 70,451 | 56,311 | 47,061 | 45,836 | 33,316 |
| Operating Income (Loss) | (89,379) | 23,989 | (73,787) | (70,451) | (56,311) | (47,061) | (45,836) | (33,316) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (75,778) | 33,174 | (65,604) | (61,522) | (46,735) | (36,343) | (33,885) | (25,981) |
| Tax Provision | 190.00 | 170.00 | 108.00 | 139.00 | 98.00 | 136.00 | 92.00 | 53.00 |
| Net Income (Loss) | (75,968) | 33,004 | (65,712) | (61,661) | (46,833) | (36,479) | (33,977) | (26,034) |
| Earnings Per Share (Basic) | (0.35) | 0.19 | (0.37) | (0.36) | (0.27) | (0.23) | (0.20) | (0.18) |
| Earnings Per Share (Diluted) | (0.35) | (0.37) | (0.27) | (0.23) | (0.20) | (0.18) | ||
| Weighted Average Shares Outstanding (Basic) | 217,326 | 177,596 | 175,469 | 172,647 | 172,051 | 157,922 | 171,630 | 148,239 |
| Weighted Average Shares Outstanding (Diluted) | 217,326 | 175,469 | 172,051 | 157,922 | 171,630 | 148,239 | ||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About GPCR
Structure Therapeutics Inc. (NASDAQ: GPCR) is a stock listed on the Nasdaq Stock Market under the ticker symbol GPCR. It last traded at $18.30 (Nov 17, 2026, 12:31 PM ET), down 1.4% on the day. That gives Structure Therapeutics a market capitalisation of $1.4B.
Over the past 52 weeks GPCR has traded between $18.70 and $94.90.
For the quarter ended Mar 31, 2026 it reported a net loss of $76.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$76.0M |
| Dec 31, 2025 | — | $33.0M |
| Sep 30, 2025 | — | -$65.7M |
| Jun 30, 2025 | — | -$61.7M |
From Structure Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…